Post-Approval Study of the TREO Abdominal Stent-Graft System

ID#: NCT04697784

Age: 18 years - 66+

Gender: All

Healthy Subjects: No

Study Phase: N/A

Recruitment Status: Recruiting

Start Date: January 20, 2021

End Date: July 31, 2027

Contact Information:
Gretchen Wild
954-779-6393
Summary: The purpose of this study is to determine the long-term performance of the TREO Abdominal Stent-Graft as a treatment for patients with Infrarenal Abdominal Aortic Aneurysms or Aorto-iliac Aneurysms.
Eligibility:

Inclusion Criteria:

- Willing and able to comply with all study procedures and visits.

- Written informed consent to participate in the study.

- Patient's aneurysm can be treated with the TREO Abdominal Stent-Graft System.

- Adequate data (medical records/imaging studies) available to analyze the primary endpoints for patients enrolled retrospectively.

Exclusion Criteria: • Medical, social or psychological problems that, in the opinion of the investigator, preclude patient from receiving treatment with the TREO Abdominal Stent-Graft System.
Find a Clinical Trial Find Cancer Clinical Trials